biotech
Life Science Leaders Meet at White House
Life Science Leaders Meet at White House
Kerry Grens | May 8, 2017
Heads of academia and industry mingled with the vice president and the secretary of Health and Human Services at a biotech summit.
Opinion: Preparing for Potential Disasters
Opinion: Preparing for Potential Disasters
Larissa Paschyn | Jan 25, 2017
How to increase the resiliency of biotechnology organizations in the face of emergency risks
Monsanto and Bayer Announce Approval of Massive Merger
Monsanto and Bayer Announce Approval of Massive Merger
Bob Grant | Dec 13, 2016
On Tuesday, shareholders at the agribusiness giant approved the $66 billion deal with the European pharmaceutical firm.
Oligonucleotide Therapeutics Near Approval
Oligonucleotide Therapeutics Near Approval
Catherine Offord | Dec 1, 2016
Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.
Another CRISPR Biotech Goes Public
Another CRISPR Biotech Goes Public
Bob Grant | Sep 12, 2016
CRISPR Therapeutics, the company started by a pioneer of the gene editing technology, plans to raise $90 million from an initial public offering.
That Other CRISPR Patent Dispute
That Other CRISPR Patent Dispute
Kerry Grens | Aug 31, 2016
The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.
Opinion: How to Avoid Legal Problems in Collaborative Research
Opinion: How to Avoid Legal Problems in Collaborative Research
Catherine Coombes | Aug 31, 2016
A patent dispute over CRISPR highlights the need for scientists to agree on IP ownership early.
Theranos CEO Presents New Device
Theranos CEO Presents New Device
Kerry Grens | Aug 2, 2016
The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.
The Growth of Iowa Biotech
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016
The state’s industry draws inspiration from medicine as well as agriculture.
23andMe Markets Genome Kits to Researchers
23andMe Markets Genome Kits to Researchers
Kerry Grens | Jul 14, 2016
Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.